Сахарный диабет после трансплантации печени: патогенез, факторы риска, верификация, влияние на прогноз
- Авторы: Космачева Е.Д.1, Бабич А.Э.2
-
Учреждения:
- ФГБОУ ВО КубГМУ, ГБУЗ «НИИ - ККБ№1 им. проф. С.В.Очаповского»
- КубГМУ, ГБУЗ «НИИ - ККБ№1 им. проф. С.В.Очаповского»
- Выпуск: Том 19, № 8-2 (2017)
- Страницы: 59-63
- Раздел: Статьи
- URL: https://journals.rcsi.science/2075-1753/article/view/94647
- DOI: https://doi.org/10.26442/2075-1753_19.8.2.59-63
- ID: 94647
Цитировать
Полный текст
Аннотация
Посттрансплантационный сахарный диабет (ПТСД) связан с повышенной заболеваемостью и смертностью после трансплантации печени. В обзоре представлены литературные данные о современных взглядах на патогенез, факторы риска и верификацию ПТСД в раннем и позднем посттрансплантационном периоде. Особое внимание уделяется механизмам диабетогенного действия цитостатиков и иммуносупрессантов. Понимание механизмов возникновения, управления факторами риска и раннее выявление ПТСД будут способствовать профилактике и своевременному началу лечения заболевания.
Ключевые слова
Полный текст
Открыть статью на сайте журналаОб авторах
Елена Дмитриевна Космачева
ФГБОУ ВО КубГМУ, ГБУЗ «НИИ - ККБ№1 им. проф. С.В.Очаповского»
Email: anna-babich1@yandex.ru
д-р мед. наук, доц., зав. каф. терапии №1 ФПК и ППС, зам. глав. врача по медицинской части 350029, Россия, Краснодар, ул. 1 Мая, д. 16
Анна Эдуардовна Бабич
КубГМУ, ГБУЗ «НИИ - ККБ№1 им. проф. С.В.Очаповского»
Email: anna-babich1@yandex.ru
аспирант каф. терапии №1 ФПК и ППС, врач-гастроэнтеролог 350029, Россия, Краснодар, ул. 1 Мая, д. 16
Список литературы
- Davidson J, Wilkinson A, Dantal J. et al. New-onset diabetes after transplantation: 2003 International consensus guidelines. Proceedings of an international expert panel meeting. Barcelona, Spain, 19 February 2003. Transplantation. 2003; 75 (Suppl. 10): SS3-24. doi: 10.1097/01.TP.0000069952.49242.3E
- Stockmann M, Steinmuller T.H, Nolting S, Neuhaus P. Posttransplant diabetes mellitus after orthotopic liver transplantation. Trans Proceed 2002; 34 (5): 1571-2.
- Wilkinson A, Davidson J, Dotta F. et al. Guidelines for the treatment and management of new-onset diabetes after transplantation1. Clin Transpl 2005; 19 (3): 291-8. doi: 10.1111/j.1399-0012.2005.00359.x
- Sharif A, Hecking M, de Vries A.P.J. et al. Proceedings from an international consensus meeting on posttransplantation diabetes mellitus: recommendations and future directions. Am J Transpl 2014; 14 (9): 1992-2000. doi: 10.1111/ajt.12850
- Baid S, Cosimi A.B, Farrell M.L. et al. Posttransplant diabetes mellitus in liver transplant recipients: risk factors, temporal relationship with hepatitis C virus allograft hepatitis, and impact on mortality. Transplantation 2001; 72 (6): 1066-72.
- Lucey M.R, Terrault N, Ojo L. et al. Long-Term Management of the Successful Adult Liver Transplant: 2012 Practice Guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation. Liver Transpl 2013; 19: 3-26.
- Ruiz-Rebollo M.L, Sánchez-Antolín G, García-Pajares F. et al. Risk of development of the metabolic syndrome after orthotopic liver transplantation. Transplant Proc 2010; 42 (2): 663-5.
- Pageaux G.P, Faure S, Bouyabrine H. et al. Long-term outcomes of liver transplantation: diabetes mellitus. Liver Transpl 2009; 15 (Suppl. 2): 79-82.
- Laura De Luca, Rachel Westbrook, Emmanuel A. Tsochatzis Royal Metabolic and cardiovascular complications in the liver transplant recipient. Ann Gastroenterol 2015; 28 (2): 182-92.
- Laish I., Braun M, Mor E. Metabolic syndrome in liver transplant recipients: prevalence, risk factors, and association with cardiovascular events. Liver Transpl 2011.
- Laryea M., Watt K.D, Molinari M.et al. Metabolic syndrome in liver transplant recipients: prevalence and association with major vascular events. Liver Transpl 2007; 13 (8): 1109-14.
- Bianchi G., Marchesini G, Marzocchi R. et al. Metabolic syndrome in liver transplantation: relation to etiology and immunosuppression. Liver Transpl 2008; 14 (11): 1648-54.
- Cole E.H, Johnston O, Rose C.L, Gill J.S. Impact of acute rejection and new-onset diabetes on longterm transplant graft and patient survival. Clin J Am Soc Nephrol 2008; 3: 814-21.
- Watt K.D., Pedersen R.A, Kremers W.K. et al. Evolution of causes and risk factors for mortality post-liver transplant: results of the NIDDK long-term follow-up study. Am J Transplant 2010; 10 (6): 1420-7.
- John P.R, Thuluvath P.J. Outcome of liver transplantation in patients with diabetes mellitus: a case-control study. Hepatology 2001; 34 (5): 889-95.
- Kato T. Glucose intolerance, as пeflected by hemoglobin A1c level, is associated with the incidence and severity of transplant coronary artery disease. J Am Coll Cardiology 2004; 43 (6): 1034
- Veldt B.J., Poterucha J.J, Watt K.D. et al. Insulin resistance, serum adipokines and risk of fibrosis progression in patients transplanted for hepatitis C. Am J Transplant 2009; 9 (6); 1406-13.
- Hanouneh I.A, Feldstein A.E., McCullough A.J. et al. The significance of metabolic syndrome in the setting of recurrent hepatitis C after liver transplantation. Liver Transpl 2008; 14 (9): 1287-93.
- Moon J.I., Barbeito R, Faradji R.N. et al. Negative impact of new-onset diabetes mellitus on patient and graft survival after liver transplantation: long-term follow up. Transplantation 2006; 82 (12): 1625-8.
- Скляник И.А., Шамхалова М.Ш., Шестакова М.В. Посттрансплантационный сахарный диабет. Обзор литературы. Сахарный диабет. 2015; 18 (2): 20-31.
- Алгоритмы специализированной медицинской помощи больным сахарным диабетом. Под ред. И.И.Дедова, М.В.Шестаковой, А.Ю.Майорова. Вып. 8. М.: УП ПРИНТ, 2017.
- Общероссийская общественная организация трансплантологов «Российское трансплантологическое общество». Трансплантация сердца. Национальные клинические рекомендации, 2013 год.
- Bayer N., Philip T., Cochetti P.et al. Association of metabolic syndrome with development of new onset diabetes after transplantation. Transplantation 2010; 90: 861-6.
- Porrini E., Silva I., Ibernon M. et al. The natural history of prediabetes and new onset diabetes after transplantation. Proceedings of the ERA-EDTA 50th Congress; 2013; May 18-21; Istanbul, Turkey. p. Abstract T002.
- Kuo H.T, Sampaio M.S, Ye X. et al. Risk factors for new-onset diabetes mellitus in adult liver transplant recipients, an analysis of the Organ Procurement and Transplant Network/United Network for Organ Sharing database. Transplantation 2010; 89 (9): 1134-40.
- Porrini E., Delgado P, Alvarez A. et al. The combined effect of pre-transplant triglyceride levels and the type of calcineurin inhibitor in predicting the risk of new onset diabetes after renal transplantation. Nephrol Dial Transplant 2007; 23: 1436-41.
- Hornum M., Jørgensen K.A, Hansen JM et al. New-onset diabetes mellitus after kidney transplantation in Denmark. Clin J Am Soc Nephrol 2010; 5: 709-16.
- Vincenti F., Friman S., Scheuermann E. et al. Results of an international, randomized trial comparing glucose metabolism disorders and outcome with cyclosporine versus tacrolimus. Am J Transplant 2007; 7: 1506-14.
- Wissing K., Kuypers, D., Abramowicz, D. et al. Conversion from tacrolimus to cyclosporin A improves glucose metabolism in patients with new-onset diabetes after transplantation: Interim analysis of a prospective and randomized study. Presented at the 16th ESOT Congress; September 8-11, 2013; Vienna, Austria. p. Abstract 231475.
- Pham P.C.T, Pham P.M.T, Pham S.V. et al. Hypomagnesemia in patients with type 2 diabetes. Clin J Am Soc Nephrol 2007; 2 (2): 366-73. doi: 10.2215/cjn.02960906
- Van Laecke S, Van Biesen W., Verbeke F. et al. Posttransplantation hypomagnesemia and its relation with immunosuppression as predictors of new-onset diabetes after transplantation. Am J Transplant 2009; 9 (9): 2140-9. doi: 10.1111/j.1600-6143.2009.02752.x
- Augusto J.F., Subra J.F., Duveau A. et al. Relation between pretransplant magnesemia and the risk of new onset diabetes after transplantation within the first year of kidney transplantation. Transplantation 2014; 97 (11): 1155-60.
- Bloom R.D., Lake J.R. Emerging issues in hepatitis C virus-positive liver and kidney transplant recipients. Am J Transplant 2006; 6 (10): 2232-7.
- Bigam D.L., Pennington J.J, Carpentier A.et al. Hepatitis C-related cirrhosis: a predictor of diabetes after liver transplantation. Hepatology 2000; 32: 87-90.
- Trail K.C, McCashland T.M, Larsen J.L. et al. Morbidity in patients with posttransplant diabetes mellitus following orthotopic liver transplantation. Liver Transpl Surg 1996; 2: 276-83.
- Tueche S.G. Diabetes mellitus after liver transplant new etiologic clues and cornerstones for understanding. Transplant Proc 2003; 35: 1466-8.
- Chan J.C, Cockram C.S, Critchley J.A. Drug-induced disorders of glucose metabolism. Mechanisms and management. Drug Saf 1996; 15: 135-57.
- Yates C.J, Cohney S.J. Prediction and diagnosis of post transplant diabetes. Curr Diabetes Rev 2015; 11 (3): 170-4.
- Valderhaug T.G, Hjelmesaeth J, Hartmann A.et al. The association of early post-transplant glucose levels with long-term mortality. Diabetologia 2011; 54: 1341-9.
- Sharif A, Moore R.H, Baboolal K. The use of oral glucose tolerance tests to risk stratify for new-onset diabetes after transplantation: An underdiagnosed phenomenon. Transplantation 2006; 82: 1667-72.
- Lane J.T, Dagogo-Jack S. Approach to the patient with new-onset diabetes after transplant (NODAT). J Clin Endocrinol Metab 2011; 96 (11): 3289-97.
- Valderhaug T.G, Jenssen T., Hartmann A. et al. Fasting plasma glucose and glycosylated hemoglobin in the screening for diabetes mellitus after renal transplantation. Transplantation 2009; 88: 429-34.
- Armstrong K.A, Prins J.B, Beller E.M et al. Should an oral glucose tolerance test be performed routinely in all renal transplant recipients? Clin J Am Soc Nephrol 2006; 1: 100-8.
- Hecking M, Werzowa J, Haidinger M. et al. New-onset diabetes after transplantation: Development, prevention, treatment. Nephrol Dial Transplant 2013; 28: 550-66. PubMed: 23328712.
- Hecking M, Kainz A, Werzowa J et al. Glucose metabolism after renal transplantation. Diabetes Care 2013; 36: 2763-71. PubMed: 23656979.
- Caillard S, Eprinchard L, Perrin P et al. Incidence and risk factors of glucose metabolism disorders in kidney transplant recipients: Role of systematics screening by oral glucose tolerance test. Transplantation 2011; 91: 757-64.
- Valderhaug T.G, Hjelmesaeth J., Jenssen T. et al. Early posttransplantation hyperglycemia in kidney transplant recipients is associated with overall longterm graft losses. Transplantation 2012; 94: 714-20.
- American Diabetes Association. Standards of medical care in diabetes-2013. Diabetes Care 2013; 36 (Suppl. 1): S11-S66.
- Sharif A., Baboolal K. Diagnostic application of the A assay in renal disease. J Am Soc Nephrol 2010; 21: 383-5. PubMed: 20133482.
- Shabir S., Jham S, Harper L. et al. Validity of glycated haemoglobin to diagnose new onset diabetes after transplantation. Transplant Int 2013; 26: 315-21.
- Werzowa J, Hecking M, Haidinger M. et al. Curr Diab Rep 2015; 15: 27. doi: 10.1007/s11892-015-0601-x
- Perito E.R., Lustig R.H, Rosenthal P. Prediabetes in Pediatric Recipients of Liver Transplant: Mechanism and Risk Factors. J Pediatr 2017; 182: 223-31. e3. doi: 10.1016/j.jpeds.2016.11.070. Epub 2016 Dec 29.
- Bergrem H.A, Valderhaug T.G, Hartmann A. et al. Undiagnosed diabetes in kidney transplant candidates: A case-finding strategy. Clin J Am Soc Nephrol 2010; 5: 616-22. PubMed: 20133490.
- Tietge U.J., Selberg O, Kreter A et al. Alterations in glucose metabolism associated with liver cirrhosis persist in the clinically stable long-term course after liver transplantation. Liver Transpl 2004; 10 (8): 1030-40.
- Бондарь И.А., Климонтов В.В., Мигуськина Е.И. и др. Трансплантация печени по поводу первичного билиарного цирроза у больного сахарным диабетом. Cахарный диабет. 2011; 3: 113-5.
- Sharif A., Baboolal K. Risk factors for new onset diabetes after transplantation. Nat Rev Nephrol 2010; 6: 415-23.
- Hampton T.. Diabetes drugs tied to fractures in women. JAMA 2007; 297: 1645-7.
- Pham P.T., Pham P.C., Lipshutz G.E. et al. New Onset diabetes mellitus after solid organ transplantation. Endocrinol Metab Clin N Am 2007; 36: 873-90.
- Valantine H., Rickenbaker P., Kemna M. et al. Metabolic abnormalities characteristic of dysmetabolic syndrome predict the development of transplant coronary artery disease. Circulation 2001; 103: 2144-52.
- Bodziak K.A, Hricik D.E. New-onset diabetes mellitus after solid organ transplantation. Transplant Int2009; 22: 519-30.
- Hjelmesaeth J., Hartmann A., Leivestad T. et al. The impact of early-diagnosed new-onset post-transplantation diabetes mellitus on survival and major cardiac events. Kidney Int 2006; 69: 588-95.
- Готье С.В., Хомяков С.М., Арзуманов С.В. Трансплантация печени. Национальные клинические рекомендации. (Утверждены решением Координационного Совета общероссийской общественной организации трансплантологов «Российское трансплантологическое общество».) М., 2013. http://transpl.ru/images/cms/ /data/pdf/nacional_nye_klinicheskie_rekomendacii_po_transplantacii_pecheni.pdf nacional_nye_klinicheskie_rekomendacii_po_transplantacii_pecheni.pdf [in Russian]
- Готье С.В., Мойсюк Я.Г. Трансплантология. Фармакотерапия без ошибок. М., 2014.
- Государственный реестр лекарственных средств: grls.rosminzdrav.ru.
- Johnston O, Rose C.L, Webster A.C, Gill J.S. Sirolimus is associated with new-onset diabetes in kidney transplant recipients. J Am Soc Nephrol 2008; 19: 1411-8.